JP2004535473A5 - - Google Patents

Download PDF

Info

Publication number
JP2004535473A5
JP2004535473A5 JP2003515226A JP2003515226A JP2004535473A5 JP 2004535473 A5 JP2004535473 A5 JP 2004535473A5 JP 2003515226 A JP2003515226 A JP 2003515226A JP 2003515226 A JP2003515226 A JP 2003515226A JP 2004535473 A5 JP2004535473 A5 JP 2004535473A5
Authority
JP
Japan
Prior art keywords
implant
sustained release
tablet
pharmaceutically active
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003515226A
Other languages
English (en)
Japanese (ja)
Other versions
JP4913321B2 (ja
JP2004535473A (ja
Filing date
Publication date
Priority claimed from AUPR6024A external-priority patent/AUPR602401A0/en
Application filed filed Critical
Publication of JP2004535473A publication Critical patent/JP2004535473A/ja
Publication of JP2004535473A5 publication Critical patent/JP2004535473A5/ja
Application granted granted Critical
Publication of JP4913321B2 publication Critical patent/JP4913321B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003515226A 2001-06-29 2002-07-01 徐放性医薬組成物 Expired - Fee Related JP4913321B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR6024A AUPR602401A0 (en) 2001-06-29 2001-06-29 Sustained release delivery system
AUPR6024 2001-06-29
PCT/AU2002/000866 WO2003009833A1 (en) 2001-06-29 2002-07-01 Sustained release delivery system

Publications (3)

Publication Number Publication Date
JP2004535473A JP2004535473A (ja) 2004-11-25
JP2004535473A5 true JP2004535473A5 (cg-RX-API-DMAC7.html) 2005-10-27
JP4913321B2 JP4913321B2 (ja) 2012-04-11

Family

ID=3829990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003515226A Expired - Fee Related JP4913321B2 (ja) 2001-06-29 2002-07-01 徐放性医薬組成物

Country Status (9)

Country Link
US (1) US8197839B2 (cg-RX-API-DMAC7.html)
EP (1) EP1411905A4 (cg-RX-API-DMAC7.html)
JP (1) JP4913321B2 (cg-RX-API-DMAC7.html)
CN (1) CN1536988A (cg-RX-API-DMAC7.html)
AU (2) AUPR602401A0 (cg-RX-API-DMAC7.html)
BR (1) BR0210630A (cg-RX-API-DMAC7.html)
CA (1) CA2452075C (cg-RX-API-DMAC7.html)
NZ (1) NZ529858A (cg-RX-API-DMAC7.html)
WO (1) WO2003009833A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
NZ530550A (en) * 2001-09-11 2004-11-26 Smart Drug Systems Inc Preparation of sustained release pharmaceutical composition
PL1696822T3 (pl) * 2003-11-13 2010-08-31 Psivida Inc Wstrzykiwane implanty o opóźnionym wydzielaniu mające matrycę rdzenia i powłokę podatne na erozję biologiczną
BRPI0511694A (pt) * 2004-05-31 2008-01-08 Smart Drug Systems Inc composições de liberação controlada
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
WO2007123511A2 (en) * 2006-03-24 2007-11-01 Infinity Pharmaceuticals, Inc. Dosing regimens for the treatment of cancer
US20090005869A1 (en) * 2006-12-15 2009-01-01 University Of Virginia Patent Foundation Device which Attaches into a Joint and Carries a Payload of Controlled Release Drugs and Related Method thereof
NZ552290A (en) * 2006-12-21 2009-05-31 Bomac Research Ltd Tablet fomulation
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明(cyclopamine)類似物類
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
WO2009086451A1 (en) 2007-12-27 2009-07-09 Infinity Pharmaceuticals, Inc. Methods for stereoselective reduction
US20100297118A1 (en) * 2007-12-27 2010-11-25 Macdougall John Therapeutic Cancer Treatments
JP2011522773A (ja) * 2007-12-27 2011-08-04 インフィニティ ファーマスーティカルズ、インク. 治療剤での癌の処置方法
US9005649B2 (en) 2009-07-14 2015-04-14 Board Of Regents, The University Of Texas System Methods for making controlled delivery devices having zero order kinetics
CA2769795C (en) 2009-08-05 2020-01-07 Infinity Pharmaceuticals, Inc. Enzymatic transamination of cyclopamine analogs
WO2011088404A1 (en) * 2010-01-15 2011-07-21 Infinity Pharmaceuticals , Inc Treatment of fibrotic conditions using hedgehog inhibitors
US9376447B2 (en) 2010-09-14 2016-06-28 Infinity Pharmaceuticals, Inc. Transfer hydrogenation of cyclopamine analogs
ITTO20111188A1 (it) 2011-12-22 2013-06-23 Vhit Spa Pompa a cilindrata variabile e metodo di regolazione della sua cilindrata
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
BR112017026103B1 (pt) 2015-06-04 2023-10-03 Sol-Gel Technologies Ltd Composições tópicas com composto inibidor de hedgehog, sistema de entrega tópica e seus usos
FI20155779A7 (fi) * 2015-10-30 2017-05-01 Solani Therapeutics Ltd Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
CA3087238A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
CN111989068B (zh) 2018-05-24 2024-10-25 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
CN110559431B (zh) * 2019-10-11 2023-02-28 南京农业大学 一种巨型艾美耳球虫纳米亚单位疫苗及其制备方法和应用
JP2023509981A (ja) * 2020-01-10 2023-03-10 エキリーブル バイオファーマシューティカルズ べスローテン フェンノートシャップ アベルメクチンによる神経障害の治療
EP4329734A4 (en) 2021-04-26 2025-04-02 Celanese EVA Performance Polymers LLC Implantable device for the delayed release of a macromolecular drug compound
CN116687882A (zh) * 2023-07-06 2023-09-05 杭州高成生物营养技术有限公司 一种布洛芬缓释小丸及其制备方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4331652A (en) * 1979-09-12 1982-05-25 Eli Lilly And Company Controlled release parasitic formulations and method
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
DE3681348D1 (de) * 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
SE444801B (sv) 1985-06-28 1986-05-12 Johan Magnus Ullman Fender
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
JPH01500899A (ja) * 1986-05-16 1989-03-30 ザ・ステイト・オブ・ビクトリア 生物適合性インプラント
US5342622A (en) * 1986-05-16 1994-08-30 The State Of Victoria Subdermal biocompatible implants
US5028430A (en) * 1987-05-08 1991-07-02 Syntex (U.S.A.) Inc. Delivery systems for the controlled administration of LHRH analogs
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
JPH0618958B2 (ja) * 1989-03-08 1994-03-16 株式会社クラレ 多層容器および包装体
ATE90203T1 (de) 1989-03-17 1993-06-15 Pitman Moore Inc Kontrollierte, verzoegerte wirkstofffreisetzung von makromolekularen proteinen.
ES2058923T3 (es) 1989-06-21 1994-11-01 Univ Brown Res Found Sistema para terapia neurologica.
US5091185A (en) 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
JPH11508224A (ja) * 1990-08-09 1999-07-21 エンドコン・インコーポレーテッド 多重ドラッグデリバリーシステム
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
IS3778A7 (is) * 1990-10-31 1992-05-02 Amgen Inc. Aðferð til að gefa dýrum vaxtarhormón, þar sem gefnu magni er stýrt
US5211951A (en) * 1991-07-24 1993-05-18 Merck & Co., Inc. Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
JPH06321803A (ja) * 1993-05-17 1994-11-22 Kirin Brewery Co Ltd 水溶性ペプチドホルモンの徐放性製剤
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
KR100210509B1 (ko) * 1996-01-10 1999-07-15 성재갑 지속성 동물 성장 호르몬 제형 및 이의 제조 방법
FR2745180B1 (fr) * 1996-02-23 1998-05-07 Dow Corning Sa Procede de fabrication de dispositifs a liberation controlee
EP1014970A1 (en) * 1997-09-23 2000-07-05 Pfizer Limited Parasiticidal formulations
AUPP279698A0 (en) 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
WO2000013666A1 (en) 1998-09-05 2000-03-16 Seung Jin Lee Biodegradable particulate polymeric preparation and process for producing thereof
TWI246928B (en) * 1998-09-10 2006-01-11 Sumitomo Pharma Long time drug-sustained release preparation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU6283299A (en) 1998-10-01 2000-04-17 Elan Pharma International Limited Controlled release nanoparticulate compositions
CA2379909C (en) 1999-08-06 2011-01-04 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
JP4230621B2 (ja) 1999-08-12 2009-02-25 住友ゴム工業株式会社 空気入りタイヤ
JP4757995B2 (ja) * 1999-11-10 2011-08-24 大日本住友製薬株式会社 薬物放出製剤
TW524696B (en) * 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
WO2001037811A1 (en) * 1999-11-22 2001-05-31 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6998137B2 (en) * 2000-04-07 2006-02-14 Macromed, Inc. Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
JP4504122B2 (ja) 2004-07-02 2010-07-14 株式会社マキタ 生垣バリカン

Similar Documents

Publication Publication Date Title
JP4459444B2 (ja) 多層構造を有する放出制御製剤
JP4913321B2 (ja) 徐放性医薬組成物
JP2004530721A5 (cg-RX-API-DMAC7.html)
JP4800570B2 (ja) 徐放性医薬組成物
JP2005505557A (ja) 持続放出医薬組成物の調製
JP2003517014A (ja) 即放性および徐放性成分を含有する医薬インプラントおよび投与方法
JPWO1999062501A1 (ja) 多層構造を有する放出制御製剤
JP2013049705A (ja) 持続放出医薬組成物
AU2002344686A1 (en) Sustained release delivery system
US20050118271A1 (en) Polytartrate composition
JP2005517653A5 (cg-RX-API-DMAC7.html)
JP2005517653A (ja) X線不透過性徐放性医薬器具
JP2005522418A5 (cg-RX-API-DMAC7.html)
AU2003201410B2 (en) Sustained release pharmaceutical composition
JP2008500973A (ja) 持続放出組成物
AU2003201410A1 (en) Sustained release pharmaceutical composition
AU2002344687B2 (en) Treatment of parasitic disease
JP2001199879A (ja) 薬物放出製剤
AU2002315568A1 (en) Preparation of sustained release pharmaceutical composition